Thursday November 26 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Ardana Bioscience

Ardana Bioscience was created in July 2000 to commercialise research developed over the last 28 years by the Medical Research Council (MRC) Human Reproductive Sciences Unit (HRSU) in Edinburgh, Scotland. It is an independent pharmaceutical company dedicated to improving overall well-being through reproductive health.


Contact Details:
48 Manor Place
Edinburgh
EH3 7EH
United Kingdom
Tel:+44 (0) 131 226 8550
Fax:+44 (0) 131 226 8551
Email:info@ardana.co.uk
WWW:

www.ardana.co.uk/




Loading...

Recent Publications by Ardana Bioscience:

Gonadotropin-releasing hormone analog structural determinants of selectivity for inhibition of cell growth: support for the concept of ligand-induced selective signaling.
GnRH and its receptor are expressed in human reproductive tract cancers,...
4th September, 2008
Ardana Bioscience, Edinburgh, UK. Mol Endocrinol. 2008 Jul;22(7):1711-22. Epub 2008 May 8.
DOI Direct Link
Gonadotropin-releasing hormone functionally antagonizes testosterone activation of the human androgen receptor in prostate cells through focal adhesion complexes involving Hic-5.
Gonadotropin-releasing hormone (GnRH) analogs constitute the most widely...
22nd May, 2007
Medical Research Council Human Reproductive Sciences Unit, The Queen's Neuroendocrinology. 2006;84(5):285-300. Epub 2007 Jan 4.
DOI Direct Link
Non-peptidic GnRH receptor antagonists.
Gonadotropin-releasing hormone (GnRH) or luteinizing hormone-releasing...
4th May, 2005
Ardana Bioscience, 58 Queen Street, Edinburgh, EH2 3NS, Scotland, UK. Curr Med Chem. 2004 Nov;11(22):3017-28.

Press Releases on Ardana Bioscience:

BioPortfolio Logo
AEterna Zentaris Reports Second Quarter 2009 Financial and Operating Results 11th August, 2009 AETERNA ZENTARIS INC.
All amounts are in U.S. dollars QUEBEC CITY, Aug. 11 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: AEZS, TSX: AEZ) ("the Company"), a global biopharmaceutical company focused on
Senetek Announces Termination of Invicorp(R) License Agreement With Ardana Bioscience Limited 3rd July, 2008
NAPA, California, July 3 /PRNewswire/ -- Senetek PLC (OTC Bulletin Board: SNKTY), a Life Sciences company engaged in the development of technologies that target the science of healthy aging, today
XENTION DISCOVERY LAUNCHED WITH ACQUISITION OF AUTOPATCHÒ BUSINESS FROM 1st August, 2002 Xention
  XENTION DISCOVERY LAUNCHED WITH ACQUISITION OF AUTOPATCHÒ BUSINESS FROM CeNeS AND £4 MILLION INVESTMENT LED BY MVM CAMBRIDGE, UK, 15 August 2002.

Ardana Bioscience Clinical Trials:

Open-Label Study of ARD-0403 in Testosterone Deficient Men

Ardana Bioscience Patents:

US Patent No.Title
7361633 Screening method and anti-tumor drug candidate obtained therefrom
7098305 Sustained release of microcrystalline peptide suspensions
6627600 Compressed microparticles for dry injection

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 333 times since April 2007, the link to the organisation's website has been followed 85 times

Recent Search Terms used to find this page: ardana bioscience | ardana bioscience 2009 | ardana bioscience news 2009 | firma ardana bioscience | ardana | ardana bioscience 2009 | ardana uk contact | ardana biosciences | patent status of AEZS-130 | Ardana Bioscience Ltd. AEZS-130 | .

Search for more companies in Edinburgh

Search for more companies in



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Ardana Bioscience

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.